Results 11 to 20 of about 268,831 (258)

i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists [PDF]

open access: yesNature Communications
The ability to leverage antibodies to agonize disease relevant biological pathways has tremendous potential for clinical investigation. Yet while antibodies have been successful as antagonists, immune mediators, and targeting agents, they are not readily
Matthew G. Romei   +16 more
doaj   +3 more sources

Antibody Engineering for the Development of Therapeutic Antibodies

open access: yesMolecules and Cells, 2005
Therapeutic antibodies represent one of the fastest growing areas of the pharmaceutical industry. There are currently 19 monoclonal antibodies in the market that have been approved by the FDA and over 150 in clinical developments. Driven by innovation and technological developments, therapeutic antibodies are the second largest biopharmaceutical ...
Sang Jick Kim
exaly   +3 more sources

Outsmarting Pathogens with Antibody Engineering [PDF]

open access: yesAnnual Review of Chemical and Biomolecular Engineering, 2023
Jennifer Maynard
exaly   +2 more sources

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review [PDF]

open access: yesInternational Journal of Molecular Sciences, 2022
Hervé Watier   +2 more
exaly   +2 more sources

A seroepidemiological survey of adenovirus type 7 circulation among healthy adults in China and in Sierra Leone, West Africa

open access: yesFrontiers in Public Health, 2023
Adenovirus type 7 (HAdV7) is one of the most pathogenic human adenoviruses (HAdVs) and can cause severe illness and even death, particularly in people with weakened immune systems.
Busen Wang   +12 more
doaj   +1 more source

Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology

open access: yesVeterinary Research, 2021
Brucella spp. are Gram-negative, facultative intracellular bacteria that cause brucellosis in humans and various animals. The threat of brucellosis has increased, yet currently available live attenuated vaccines still have drawbacks.
Xiaodong Zai   +8 more
doaj   +1 more source

Antibody Engineering for Pursuing a Healthier Future [PDF]

open access: yesFrontiers in Microbiology, 2017
Shihua Wang, Sumei Ling, Rongzhi Wang
exaly   +2 more sources

In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance

open access: yesCommunications Biology, 2021
Lu Shan et al. present a structure-guided approach to engineer a monovalent form of the fragment crystallizable (Fc) region of an IgG4 antibody to adapt multiple versions of half-life extension modifications and bispecific targeting.
Lu Shan   +12 more
doaj   +1 more source

A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants

open access: yesVaccines, 2022
With the emergence and rapid spread of new pandemic variants, especially variants of concern (VOCs), the development of next-generation vaccines with broad-spectrum neutralizing activities is of great importance.
Rui Wang   +19 more
doaj   +1 more source

A novel Galleria mellonella experimental model for zoonotic pathogen Brucella

open access: yesVirulence, 2023
Brucellosis is a major threat to public health and animal husbandry. Several in vivo vertebrate models, such as mice, guinea pigs, and nonhuman primates, have been used to study Brucella pathogenesis, bacteria-host interactions, and vaccine efficacy ...
Shuyi Wang   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy